Clinical Trials Browser

Phase 1 × LY3022855 × Clear all

NCT02265536 2024-10-28

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Phase 1 Completed

34 enrolled 17 charts

Neoplasm Metastasis, Neoplasms

NCT02718911 2023-10-16

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Phase 1 Completed

72 enrolled 23 charts

Other solid neoplasm

Solid Tumor